1.
Mastorino L, Siliquini N, Avallone G, Ortoncelli M, Quaglino P, Dapavo P, Ribero S. Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis. Dermatol Reports [Internet]. 2022 Mar. 17 [cited 2024 Nov. 22];14(3). Available from: https://www.pagepress.org/journals/dr/article/view/9282